4,5-Dihydro-2,5-dimethyl-4-oxofuran-3-yl Butyrate>96.0%(GC)25g

Piano obiettivo per contrasto di fase PLPH 10x/0,25

Boc-D-Ala-OH, 98%, 100g

2-Phenoxynicotinic acid, 98.0%, 100g

7-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)heptanoic acid, 98.0%, 100g

4-methoxy-1H-indazole-6-carboxylic acid, 98%, 250mg

[1-(2-Amino-ethyl)-piperidin-2-yl]-methanol, 95.0%, 1g

1-(2-Chloro-3-fluorophenyl)ethanamine hydrochloride, 95.0%, 250mg

3-Cyano-2-methoxybenzoic acid, 98%, 1g

Ethyl 5-amino-3-bromo-2-methylbenzoate, 98%, 100mg

(1S,4S)-2-Methyl-2,5-diazabicyclo[2.2.1]heptane dihydrochloride, 97%, 100mg

Oxazole-4-carbothioamide, 95.0%, 100mg

Butane-1,2,3-triol, 90%, 250mg